This study investigates the effects of an investigational medication on patients with advanced solid tumors. Solid tumors are abnormal masses of tissue that usually do not contain cysts or liquid areas. This study focuses on various types of solid tumors, including breast cancer, prostate cancer, cervical cancer, and others, to understand how the investigational medication impacts tumor growth and progression.
Participants in this study will undergo specific procedures to evaluate the effects of the investigational medication. These procedures may include imaging tests, blood tests, and biopsies, which involve taking a small sample of tissue for examination. The study aims to gather data on the safety and efficacy of the investigational medication, which is not yet approved for general use.
- Who can participate: Adults 18 years or older with a confirmed diagnosis of certain types of advanced solid tumors, such as breast or prostate cancer, may be eligible. Participants must have disease progression after recent treatment and meet specific health criteria, including a performance status of 0-1 and measurable lesions.
- Study details: Participants will receive an investigational medication to assess its effects on tumor growth. Some participants may receive a placebo, an inactive substance that looks like the investigational medication but does not contain any medicine. The study will include various tests and assessments to monitor health and tumor response.
